Company Details
Overview
Develops topical hedgehog pathway inhibitor for basal cell carcinomas.
Total Raised
$90 M
Rounds
2
Links
Verticals
Biotechnology
Medical Device
Therapeutics
Investment History
Equity
Nov 2018
$70M
Series B
Jul 2017
$20M
Develops topical hedgehog pathway inhibitor for basal cell carcinomas.
Total Raised
$90 M
Rounds
2
Links
Verticals
Equity
Nov 2018
$70M
Series B
Jul 2017
$20M